Skip to main content

EU regulator promises speedy review of potential COVID-19 drug remdesivir

The European health regulator said on Friday its panel would conduct a speedy review of the potential COVID-19 drug, remdesivir.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.